Working to Eradicate Gynecologic Cancers

338
A prospective phase 0 study on the effects of anesthetic selection on serum miRNA profiles during primary cytoreductive surgery for suspected ovarian cancer

Saturday, March 28, 2015: 9:55 AM
Salon C-D (Hilton Chicago)
K. M. Elias1,2,3,4, A. Fusco5, S. Kang1, D. Michaud1, R. S. Berkowitz1,2,3, N. S. Horowitz1,2,3 and G. Frendl1,2
1Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Dana-Farber Cancer Institute, Boston, MA, 4Surgical ICU Translational Research Center, Boston, MA, 5Firefly BioWorks, Inc., Cambridge, MA